The current approach to patients with invasive non-typeable H. influenza disease is based upon past experience with the type b strains. In areas where clinicians cannot obtain typing information in a timely manner, issues concerning treatment and prophylaxis should be approached as if the patients were infected with a type b strain. This approach will not change until further information becomes available on invasive non-typeable H. influenzae infections in children.